MUMBAI, India, Aug. 31 -- Intellectual Property India has published a patent application (202641100747 A) filed by Dr. Nair Sreecha Chandran; Dr. Lubna Afroz; Dr. Bindu Pavan V; Dr. Malathesh P; Dr. Sunil Kumar M S; Dr. Mahadeva Swamy M; Dr. Sowmyashree A. S.; and Ms. Nisha C L on August 20, 2026, for Personalized Diabetes Management System Using Machine Learning And Artificial Intelligence..
Inventors include Dr. Nair Sreecha Chandran; Dr. Lubna Afroz; Dr. Bindu Pavan V; Dr. Malathesh P; Dr. Sunil Kumar M S; Dr. Mahadeva Swamy M; Dr. Sowmyashree A. S.; and Ms. Nisha C L.
The application for the patent was published on August 28, 2026, under issue no. 35/2026.
Abstract: Abstract A Personalized Diabetes Management System Using Machine Learning and Artificial Intelligence is disclosed. The system integrates continuous glucose monitoring devices, wearable sensors, IoT communication networks, cloud computing infrastructure, machine learning prediction models, and artificial intelligence-based recommendation engines to provide individualized diabetes care. The invention continuously collects physiological and behavioral data, predicts future glucose fluctuations, identifies risk conditions, and generates personalized insulin, dietary, and lifestyle recommendations. Adaptive learning mechanisms improve prediction accuracy over time. The system enhances glycemic control, reduces diabetes-related complications, improves patient adherence, and supports healthcare professionals through intelligent clinical decision-making. The invention enables proactive, predictive, and personalized diabetes management within modern digital healthcare ecosystems.
Disclaimer: Curated by HT Syndication.
